Company / Profit Margin
Anixa Biosciences Inc Profit Margin History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-5978.1%
FY2024
5-year range
-6473.8% / -1280.3%
FY2020-FY2024
Trend
+7.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -6473.8% in FY2023 to -14.9% in FY2016.
Based on SEC 10-K filings.
-5978.1% in FY2024 with a 10-year CAGR of -3385.8%.
Declined from -2530.1% to -5978.1% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -4697.8pp
- 10-Year Change
- -3385.8pp
Key checks
Key Insights
- In FY2024, profit margin increased 7.7% year-over-year.
- Peak profit margin was recorded in FY2016.
- Lowest profit margin in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -5978.1% | +7.7% |
| FY2023 | -6473.8% | -155.9% |
| FY2022 | -2530.1% | +45.7% |
| FY2020 | -4658.8% | -263.9% |
| FY2019 | -1280.3% | +7.3% |
| FY2018 | -1381.8% | +17.4% |
| FY2017 | -1672.1% | -11122.4% |
| FY2016 | -14.9% | +94.3% |
| FY2015 | -261.9% | +89.9% |
| FY2014 | -2592.3% | -252.5% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026